Showing results (951-960 of 1,427) with videos related to

Sort By:
Pageof 143
Investigational New Drugs|September 1, 2005
Phase I and pharmacokinetic study of Bay 38-3441, a camptothecin glycoconjugate, administered as a 30-minute infusion daily for five days every 3 weeks in patients with advanced solid malignanciesEric X Chen, Gerald Batist, Lillian L Siu, et al.
American Journal of Clinical Oncology|June 7, 2006
Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 casesPaula N Fishman, Gregory R Pond, Malcolm J Moore, et al.
Pacing and Clinical Electrophysiology : PACE|February 3, 2017
Healthcare Utilization and Quality of Life Improvement after Ablation for Paroxysmal AF in Younger and Older PatientsAngelo B Biviano, Tina D Hunter, Gopi Dandamudi, et al.
British Journal of Haematology|March 23, 2011
Standard clinical practice underestimates the role and significance of erythropoietin deficiency in sickle cell diseaseSantosh Saraf, Mohammed Farooqui, Giovanni Infusino, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 13, 2015
Improving hearing loss gene testing: a systematic review of gene evidence toward more efficient next-generation sequencing-based diagnostic testing and interpretationAhmad N Abou Tayoun, Saeed H Al Turki, Andrea M Oza, et al.
Communications Biology|May 10, 2019
Automated four-dimensional long term imaging enables single cell tracking within organotypic brain slices to study neurodevelopment and degenerationJeremy W Linsley, Atmiyata Tripathi, Irina Epstein, et al.
Gynecologic Oncology|April 22, 2008
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II ConsortiaHalla S Nimeiri, Amit M Oza, Robert J Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2015
Discovery of heterocyclic sulfonamides as sphingosine 1-phosphate receptor 1 (S1P1) antagonistsEdward J Hennessy, Gurmit Grewal, Kate Byth, et al.
Water Research|June 13, 2026
PFA technology: Production, safety and wastewater deployment analysisJonathan I Mendez-Ruiz, Kati Bell, John W Norton, et al.
Gynecologic Oncology Reports|June 22, 2026
Refractory ultra-high-risk Choriocarcinoma achieving complete response to intensive multi-agent and intrathecal chemotherapy and anti-PD-L1 therapyLaura Venegas, Brooke Grant, Ana C Veneziani, et al.
Pageof 143